Mar 16, 2019
Approved for: 1.5 **
The prevalence of major depressive disorder in individuals with kidney disease, specifically those on dialysis is significantly higher than the general population. Estimates range from a 25-33% prevalence rate in this population and the presence depression is associated with increased risks of premature death, hospitalization, nonadherence, and a decreased quality of life. Further, in lieu of the pharmacological burden, time constraints and other psychosocial barriers most CKD Stage 5 patients deal, traditional approaches to managing depression (antidepressants and psychotherapy) are often rejected by both patients and professionals. Thus, teaching CKD Stage 5 patients’ self- management approaches to overcoming depression is critical. This activity will describe interventions for patients with signs and symptoms of depression, identify the DSM V criteria for its diagnosis, and identify best practices for educating patients about depression.
Faculty: Mark Meier, MSW, LICSW
Cost: Free for NKF Members / $25 for non-members